These high TGF-β levels in tumor tissues, including cervical cancer, correlate with markers of higher metastatic phenotype and/or poor patient outcome [32], and many tumor cells exhibit increased invasiveness in response to TGF-β [33]. This evidence concerns the gene TGFB1 and cervical cancer.